NASILA PHARMA LIMITED

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers

Active 1

Khan, Monsur Yazdani
Born in September 1961
Individual (1 offspring)
Officer
2019-01-31 ~ now
OF - Director → CIF 0
Mr Monsur Yazdani Khan
Born in September 1961
Individual (1 offspring)
Person with significant control
2018-06-26 ~ now
PE - Ownership of voting rights - More than 50% but less than 75% → CIF 0
PE - Right to appoint or remove directors → CIF 0
PE - Ownership of shares – More than 50% but less than 75% → CIF 0

Ceased 4

1
Chudasama, Nish
Director born in May 1969
Individual (4 offsprings)
Officer
2022-02-14 ~ 2023-11-15
OF - Director → CIF 0
2
Ali, Abdul Hamin
Director born in October 1967
Individual (4 offsprings)
Officer
2016-01-21 ~ 2021-02-01
OF - Director → CIF 0
Ali, Abdul Hamin
Individual (4 offsprings)
Officer
2022-01-01 ~ 2022-01-01
OF - Secretary → CIF 0
Mr Abdul Hamin Ali
Born in October 1967
Individual (4 offsprings)
Person with significant control
2016-04-06 ~ 2018-06-26
PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
3
Esmail, Arif
Director born in February 1963
Individual (7 offsprings)
Officer
2016-01-21 ~ 2021-02-01
OF - Director → CIF 0
Mr Arif Esmail
Born in February 1963
Individual (7 offsprings)
Person with significant control
2016-04-06 ~ 2018-06-26
PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
4
Khan, Monsur Yazdani
Businessman born in September 1961
Individual (1 offspring)
Officer
2018-06-26 ~ 2018-12-01
OF - Director → CIF 0
Mr Monsur Yazdani Khan
Born in September 1961
Individual (1 offspring)
Person with significant control
2018-06-26 ~ 2018-12-01
PE - Ownership of shares – More than 50% but less than 75% → CIF 0

Company in focus

Standard Industrial Classification

46460 - Wholesale Of Pharmaceutical Goods

Brief company account

Debtors

33,194 GBP2023-01-31

31,777 GBP2022-01-31

Cash at bank and in hand

306 GBP2023-01-31

58 GBP2022-01-31

Current Assets

33,500 GBP2023-01-31

31,835 GBP2022-01-31

Net Current Assets/Liabilities

-75,112 GBP2023-01-31

-64,263 GBP2022-01-31

Creditors

Non-current

-37,624 GBP2023-01-31

-43,578 GBP2022-01-31

Net Assets/Liabilities

-112,736 GBP2023-01-31

-107,841 GBP2022-01-31

Equity

Called up share capital

5 GBP2023-01-31

5 GBP2022-01-31

Retained earnings (accumulated losses)

-112,741 GBP2023-01-31

-107,846 GBP2022-01-31

Equity

-112,736 GBP2023-01-31

-107,841 GBP2022-01-31

Average Number of Employees

22022-02-01 ~ 2023-01-31

Other Debtors

Current

7,968 GBP2023-01-31

7,653 GBP2022-01-31

Debtors - Deferred Tax Asset

Current

25,226 GBP2023-01-31

24,124 GBP2022-01-31

Debtors

Amounts falling due within one year, Current

33,194 GBP2023-01-31

31,777 GBP2022-01-31

Bank Borrowings/Overdrafts

Current

6,060 GBP2023-01-31

6,062 GBP2022-01-31

Trade Creditors/Trade Payables

Current

34,643 GBP2023-01-31

35,057 GBP2022-01-31

Other Creditors

Current

67,909 GBP2023-01-31

54,979 GBP2022-01-31

Bank Borrowings/Overdrafts

Non-current

37,624 GBP2023-01-31

43,578 GBP2022-01-31

Number of Shares Issued (Fully Paid)

Class 1 ordinary share

5 shares2023-01-31

Par Value of Share

Class 1 ordinary share

1 GBP2022-02-01 ~ 2023-01-31

Number of Shares Issued (Fully Paid)

Class 2 ordinary share

300 shares2023-01-31

Par Value of Share

Class 2 ordinary share

1 GBP2022-02-01 ~ 2023-01-31

Number of Shares Issued (Fully Paid)

Class 3 ordinary share

100 shares2023-01-31

Par Value of Share

Class 3 ordinary share

1 GBP2022-02-01 ~ 2023-01-31

Number of Shares Issued (Fully Paid)

Class 4 ordinary share

50 shares2023-01-31

Par Value of Share

Class 4 ordinary share

1 GBP2022-02-01 ~ 2023-01-31

Equity

Called up share capital

5 GBP2022-01-31

NASILA PHARMA LIMITED
Info
Registered number 09963244
Suite 2, Cedar Court Grove Business Park, White Waltham, Maidenhead, Berkshire SL6 3LW
PRIVATE LIMITED COMPANY incorporated on 2016-01-21 (9 years 11 months). The company status is Active.
The last date of confirmation statement was made at 2024-01-20
CIF 0

Offspring entities and appointments

Active 0

Not found in our database.